Posoleucel Efficacious for Stem Cell Transplant Recipients

TUESDAY, Jan. 17, 2023 -- For recipients of allogeneic hematopoietic cell transplantation (allo-HCT) with refractory viral infections/disease, the T-cell therapy posoleucel is well tolerated and effective, according to a study published online Jan....